Hunting Hill Global Capital’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-11,007
Closed -$124K 82
2024
Q2
$124K Sell
11,007
-2,000
-15% -$23.3K 0.05% 90
2024
Q1
$161K Buy
13,007
+833
+7% +$10.9K 0.08% 97
2023
Q4
$170K Sell
12,174
-1,214
-9% -$16.9K 0.07% 93
2023
Q3
$198K Sell
13,388
-1,000
-7% -$14.1K 0.07% 80
2023
Q2
$186K Sell
14,388
-6,600
-31% -$75.2K 0.06% 85
2023
Q1
$206K Buy
20,988
+5,000
+31% +$53.4K 0.16% 46
2022
Q4
$170K Sell
15,988
-2,500
-14% -$29K 0.11% 51
2022
Q3
$193K Buy
18,488
+2,479
+15% +$32.3K 0.11% 56
2022
Q2
$202K Sell
16,009
-291
-2% -$3.09K 0.19% 51
2022
Q1
$177K Buy
+16,300
New +$198K 0.15% 66

Other funds holding DVAX

Hunting Hill Global Capital's DVAX Position: Q3 2024 in Review

Hunting Hill Global Capital sold out of Dynavax Technologies (DVAX) in Q3 2024, closing a stake of 11,007 shares — an estimated $124K sold.

Hunting Hill Global Capital first reported a position in DVAX in Q1 2022 and held it in 10 quarters. The position peaked at $206K in Q1 2023. 251 funds tracked by Wall St. Rank hold DVAX as of Q3 2024.

  • Hunting Hill Global Capital reported no remaining Dynavax Technologies position as of Q3 2024 after selling out during the quarter.
  • Hunting Hill Global Capital sold 11,007 Dynavax Technologies shares in Q3 2024, an estimated $124K.
  • Hunting Hill Global Capital first reported a position in Dynavax Technologies in Q1 2022 and held it in 10 quarters.
  • Hunting Hill Global Capital's Dynavax Technologies position peaked at $206K in Q1 2023.
  • 251 funds tracked by Wall St. Rank held Dynavax Technologies as of Q3 2024.

Based on Hunting Hill Global Capital's 13F filing for Q3 2024, filed 14 Nov 2024.